USPHS: Ketamine: Old Dog, New Tricks?


Ketamine has emerged as a potential therapy for a number of hard-to-treat disorders in the realm of behavioral health and pain. The excitement around this agent has been profound but does the present level of evidence available support these novel uses in clinical practice? This session provides an overview of novel uses of ketamine with a focus on the available evidence regarding its efficacy and safety.      

Pharmacist Learning Objectives

At the completion of this activity, participants will be able to:

  1. Describe the pharmacology of ketamine.
  2. Evaluate the evidence supporting FDA approved indications and off-label use of subanesthetic ketamine.



Technician Learning Objectives



Keith Warshany, PharmD, PhC, BCPS, NCPS
Pharmacist Practitioner, Deputy Chief Pharmacist, PGY1 Residency Program Director
US Public Health Service / Indian Health Service / Crownpoint Healthcare Facility
Learning Level: Level 1
Track: Clinical Patient Care
Session Time Slot(s): 
Monday, October 28
5:00 PM - 5:30 PM
Hilton Anatole Dallas - Cortez A
ACPE Pharmacist: 0202-0000-19-186-L01-P
CEUs Pharmacist: .05
Activity Type: